Status:
UNKNOWN
Evaluation of a Point-of-care Testing Instrument for Fecal Immunochemical Test
Lead Sponsor:
Shandong University
Conditions:
Colorectal Cancer
Eligibility:
All Genders
Brief Summary
Early detecting and removing of colorectal advanced adenomas can reduce incidence of colorectal cancer.Use of the fecal immunochemical test (FIT) for colorectal cancer (CRC) prevention is supported by...
Detailed Description
Colorectal cancer (CRC) is the third most common cancer worldwide and has become a progressively important public health problem that inevitably leads to an increase in morbidity and medical costs. Th...
Eligibility Criteria
Inclusion
- People who use the new instrument for fecal immunochemical test(FIT)
- People sign an "informed consent form"
Exclusion
- People with history of surgery in any part of the large bowel;
- People with symptoms including visible rectal bleeding, hematuria, hemorrhoid bleeds, severe and acute diarrhea and 7th type stool (Bristol feces score);
Key Trial Info
Start Date :
February 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 20 2022
Estimated Enrollment :
275 Patients enrolled
Trial Details
Trial ID
NCT05232721
Start Date
February 20 2022
End Date
April 20 2022
Last Update
February 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qilu Hospital
Jinan, Shandong, China, 250014